Lingke Pharmaceutical (Hangzhou) Co., Ltd.
 浙ICP备19010130号      Powered by www.300.cn 

FOCUSED ON THE CURE

 

Lynk Pharmaceuticals was founded by veteran drug hunters from Pfizer, Merck and Johnson & Johnson with more than 7 decades of
rich experiences in drug discovery collectively. Driven
 by a higher
purpose, Lynk Pharmaceuticals aims at growing into a market
leader for developing
innovative therapies to address unmet medical needs in
Asian Pacific and with a global reach

......

2018

Founded in

2000

160

square meters

+

+

Area covered

 people

specialized persons

Leadership                >

Investors                    >

Research                   >

Partnering              >

Lynk Pharmaceuticals Announced First Patient Dosed in Phase II Clinical Study of LNK01001

Lynk Pharmaceuticals Announced First Patient Dosed in Phase II Clinical Study of LNK01001

New
Release time:
2 days ago
Lynk Pharmaceuticals Announced First Patient Dosed in Phase II Clinical Study of LNK01001
Lynk Pharmaceuticals announced the completion of Series B financing of $50 million

Lynk Pharmaceuticals announced the completion of Series B financing of $50 million

Release time:
2021-08-27 14:33
Lynk Pharmaceuticals announced the completion of Series B financing of $50 million
Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002

Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002

Release time:
2021-08-12 15:20
Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002

Founder and CEO: Dr. Wan Zhaokui: Ph. D. of Boston University
and post-doctoral of Harvard

NEWS CENTER